UBE2D1 and hepatocellular carcinoma: Interestingly, we found that the genomic level of UBE2D1 was also associated with the serum IL-6 level of HCC patients, and patients with high serum IL-6 concentration had a higher UBE2D1 genomic level (Fig. 4e).